MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.1 Supply Disruption — Edge Pharma, LLC (Moderate Ri
MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.1 Supply Disruption — Edge Pharma, LLC (Moderate Ri is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.1; Manufacturer: Edge
| Drug name | MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.1 |
|---|---|
| Manufacturer | Edge Pharma, LLC |
| Recall/Disruption reason | Lack of Assurance of Sterility |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0412-2022 |
| Initiation date | 20211206 |
| Quantity affected | 199 syringes |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →